{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:38:33Z","timestamp":1777624713533,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejphar.2021.173914","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T21:55:32Z","timestamp":1611611732000},"page":"173914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease"],"prefix":"10.1016","volume":"896","author":[{"given":"Omidvar","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Nateghinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad A.","family":"Estiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173914_bib1","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1038\/s41598-017-03887-3","article-title":"Downregulation of blood serum microRNA 29 family in patients with Parkinson's disease","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.173914_bib2","doi-asserted-by":"crossref","first-page":"105734","DOI":"10.1016\/j.intimp.2019.105734","article-title":"Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K\/Akt signaling pathway","volume":"75","author":"Cai","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.173914_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.18632\/aging.102649","article-title":"Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1","volume":"12","author":"Cai","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.ejphar.2021.173914_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2015.00114","article-title":"Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease","volume":"9","author":"Carrieri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fncel.2015.00247","article-title":"Contra-directional expression of serum homocysteine and uric acid as important biomarkers of multiple system atrophy severity: a cross-sectional study","volume":"9","author":"Chen","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/OTT.S233338","article-title":"Circular RNA circHUWE1 is upregulated and promotes cell proliferation, migration and invasion in colorectal cancer by sponging miR-486","volume":"13","author":"Chen","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2021.173914_bib7","article-title":"The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p\/4EBP-1 mediated cap-independent HIF-1\u03b1 translation","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejphar.2021.173914_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","article-title":"MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson's disease","volume":"9","author":"Chen","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuro.2017.12.001","article-title":"LncRNA SNHG1 promotes alpha-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells","volume":"68","author":"Chen","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2021.173914_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2021.173914_bib11","doi-asserted-by":"crossref","first-page":"13256","DOI":"10.1074\/jbc.M314124200","article-title":"Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases","volume":"279","author":"Choi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.173914_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157924","article-title":"Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease","volume":"11","author":"Coupland","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.173914_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.ejphar.2021.173914_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejphar.2021.173914_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s10020-018-0059-9","article-title":"Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease","volume":"24","author":"Dong","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173914_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainresbull.2020.02.003","article-title":"LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p","volume":"157","author":"Fan","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2021.173914_bib17","first-page":"42","article-title":"Roles, functions, and mechanisms of long non-coding RNAs in cancer","volume":"14","author":"Fang","year":"2016","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.ejphar.2021.173914_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"Forrest","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.173914_bib19","first-page":"209","article-title":"Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease","volume":"43","author":"Gao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173914_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","article-title":"Ubiquitin hydrolase Uch-L1 rescues \u03b2-amyloid-induced decreases in synaptic function and contextual memory","volume":"126","author":"Gong","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.173914_bib21","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.173914_bib22","doi-asserted-by":"crossref","first-page":"105878","DOI":"10.1016\/j.intimp.2019.105878","article-title":"Long non-coding RNA Mirt2 prevents TNF-alpha-triggered inflammation via the repression of microRNA-101","volume":"76","author":"Han","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.173914_bib23","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1111\/jcmm.14678","article-title":"Long non\u2010coding RNA GAPLINC promotes angiogenesis by regulating miR\u2010211 under hypoxia in human umbilical vein endothelial cells","volume":"23","author":"He","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.173914_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2018.09.034","article-title":"Elevated microRNA-520d-5p in the serum of patients with Parkinson's disease, possibly through regulation of cereloplasmin expression","volume":"687","author":"Jin","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.173914_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejphar.2021.173914_bib26","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12035-016-9854-x","article-title":"Altered long noncoding RNA expression precedes the course of Parkinson's disease-a preliminary report","volume":"54","author":"Kraus","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","article-title":"Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/alpha-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling","volume":"233","author":"Li","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejphar.2021.173914_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","article-title":"MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3","volume":"31","author":"Li","year":"2018","journal-title":"Hum. Cell"},{"key":"10.1016\/j.ejphar.2021.173914_bib29","first-page":"22","article-title":"Protective role of microRNA-221 in Parkinson's disease","volume":"119","author":"Li","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.ejphar.2021.173914_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5603\/CJ.a2017.0133","article-title":"Identification of a peripheral blood Long non-coding RNA (Upperhand) as a potential diagnostic marker of coronary artery disease","volume":"25","author":"Li","year":"2018","journal-title":"Cardiol. J."},{"key":"10.1016\/j.ejphar.2021.173914_bib31","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1515\/hsz-2018-0431","article-title":"LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson's disease through RAB3IP","volume":"400","author":"Lin","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.173914_bib32","article-title":"Knockdown of circAPLP2 inhibits progression of colorectal cancer by regulating miR-485-5p\/FOXK1 Axis","author":"Liu","year":"2020","journal-title":"Canc. Biother. Rad."},{"key":"10.1016\/j.ejphar.2021.173914_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-017-0147-5","article-title":"Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease","volume":"7","author":"Liu","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000452521","article-title":"Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson's disease","volume":"40","author":"Liu","year":"2016","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.ejphar.2021.173914_bib35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/1440-1681.12932","article-title":"Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP\/MPP+ via regulation of gene expression","volume":"45","author":"Liu","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib36","first-page":"1597","article-title":"MicroRNA-181a regulates apoptosis and autophagy process in Parkinson's disease by inhibiting p38 mitogen-activated protein kinase (MAPK)\/c-Jun N-terminal kinases (JNK) signaling pathways","volume":"23","author":"Liu","year":"2017","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : international medical journal of experimental and clinical research"},{"key":"10.1016\/j.ejphar.2021.173914_bib37","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1002\/jcp.26608","article-title":"Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease","volume":"233","author":"Liu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib38","first-page":"7908","article-title":"LncRNA-UCA1 promotes PD development by upregulating SNCA","volume":"22","author":"Lu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.173914_bib39","article-title":"LncRNA MALAT1 targeting miR-124-3p regulates DAPK1 expression contributes to cell apoptosis in Parkinson's Disease","author":"Lu","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2021.173914_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ame2.12093","article-title":"Long noncoding RNAs in neurodevelopment and Parkinson's disease","volume":"2","author":"Lyu","year":"2019","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.ejphar.2021.173914_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11033-016-4054-3","article-title":"The roles of non-coding RNAs in Parkinson's disease","volume":"43","author":"Majidinia","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2021.173914_bib42","first-page":"9351598","article-title":"The rs13388259 intergenic polymorphism in the genomic context of the BCYRN1 gene is associated with Parkinson's disease in the Hungarian population","volume":"2018","author":"Marki","year":"2018","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.ejphar.2021.173914_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03033354","article-title":"Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder","volume":"10","author":"Mehler-Wex","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2021.173914_bib44","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Minones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2021.173914_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10571-016-0373-0","article-title":"Investigation of long non-coding RNA expression profiles in the substantia nigra of Parkinson's disease","volume":"37","author":"Ni","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2021.173914_bib47","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1080\/21691401.2019.1636805","article-title":"Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100\/ATG10 axis and PI3K\/Akt\/mTOR pathway activation","volume":"47","author":"Peng","year":"2019","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"key":"10.1016\/j.ejphar.2021.173914_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043595","article-title":"Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients","volume":"7","author":"Potashkin","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.173914_bib49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","article-title":"Role of microRNAs in the regulation of \u03b1-synuclein expression: a systematic review","volume":"9","author":"Recasens","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib50","first-page":"5153","article-title":"MicroRNA195 triggers neuroinflammation in Parkinson's disease in a Rhoassociated kinase 1 dependent manner","volume":"19","author":"Ren","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2021.173914_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003517","article-title":"Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing","volume":"10","author":"Soreq","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2021.173914_bib52","doi-asserted-by":"crossref","first-page":"23379","DOI":"10.1002\/jcp.28907","article-title":"MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model","volume":"234","author":"Sun","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fnmol.2018.00381","article-title":"MicroRNA-212-5p prevents dopaminergic neuron death by inhibiting SIRT2 in MPTP-induced mouse model of Parkinson's disease","volume":"11","author":"Sun","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2017.02.056","article-title":"Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals","volume":"645","author":"Tang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.173914_bib55","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.3900-15.2016","article-title":"microRNA-155 regulates alpha-synuclein-induced inflammatory responses in models of Parkinson disease","volume":"36","author":"Thome","year":"2016","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.ejphar.2021.173914_bib56","doi-asserted-by":"crossref","first-page":"24449","DOI":"10.18632\/oncotarget.15511","article-title":"The long noncoding RNA HOTAIR promotes Parkinson's disease by upregulating LRRK2 expression","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.173914_bib57","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1750-3639.2010.00373.x","article-title":"Profile of cognitive impairment in Parkinson's disease","volume":"20","author":"Watson","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejphar.2021.173914_bib58","first-page":"3296","article-title":"MicroRNA-181c functions as a protective factor in a 1-methyl-4-phenylpyridinium iodide-induced cellular Parkinson's disease model via BCL2L11","volume":"21","author":"Wei","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.173914_bib59","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1002\/jcp.27577","article-title":"Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib60","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s11064-011-0437-y","article-title":"Mice lacking major brain gangliosides develop parkinsonism","volume":"36","author":"Wu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2021.173914_bib61","first-page":"724","article-title":"MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression","volume":"23","author":"Wu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.173914_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases","volume":"27","author":"Wu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2021.173914_bib63","doi-asserted-by":"crossref","first-page":"8181374","DOI":"10.1155\/2018\/8181374","article-title":"LincRNA-p21 inhibits cell viability and promotes cell apoptosis in Parkinson's disease through activating alpha-synuclein expression","volume":"2018","author":"Xu","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2021.173914_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","article-title":"Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease","volume":"97","author":"Xu","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib65","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","article-title":"LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein","volume":"496","author":"Yan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173914_bib66","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","article-title":"LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein","volume":"496","author":"Yan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173914_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12031-016-0828-2","article-title":"Neuroprotective role of MicroRNA-22 in a 6-hydroxydopamine-induced cell model of Parkinson's disease via regulation of its target gene TRPM7","volume":"60","author":"Yang","year":"2016","journal-title":"J. Mol. Neurosci. : M"},{"key":"10.1016\/j.ejphar.2021.173914_bib68","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnins.2019.00218","article-title":"Elevated plasma microRNA-105-5p level in patients with idiopathic Parkinson's disease: a potential disease biomarker","volume":"13","author":"Yang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib69","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","article-title":"Altered expression levels of MicroRNA-132 and Nurr1 in peripheral blood of Parkinson's disease: potential disease biomarkers","volume":"10","author":"Yang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2021.173914_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-018-1053-4","article-title":"MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease","volume":"15","author":"Yao","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2021.173914_bib71","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease","volume":"33","author":"Yao","year":"2019","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.ejphar.2021.173914_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jocn.2019.04.004","article-title":"MicroRNA-135b alleviates MPP(+)-mediated Parkinson's disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis","volume":"65","author":"Zeng","year":"2019","journal-title":"J. Clin. Neurosci. : official journal of the Neurosurgical Society of Australasia"},{"key":"10.1016\/j.ejphar.2021.173914_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2016.06.017","article-title":"Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting alpha-synuclein protein expression","volume":"83","author":"Zhang","year":"2016","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2021.173914_bib74","article-title":"LncRNA H19 attenuates apoptosis in MPTP-induced Parkinson's disease through regulating miR-585-3p\/PIK3R3","author":"Zhang","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2021.173914_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12031-019-01349-1","article-title":"MicroRNA-326 inhibits apoptosis and promotes proliferation of dopaminergic neurons in Parkinson's disease through suppression of KLK7-mediated MAPK signaling pathway","volume":"69","author":"Zhang","year":"2019","journal-title":"J. Mol. Neurosci. : M"},{"key":"10.1016\/j.ejphar.2021.173914_bib76","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/1440-1681.13094","article-title":"KCNQ 1 OT 1, HIF 1A\u2010AS 2 and APOA 1\u2010AS are promising novel biomarkers for diagnosis of coronary artery disease","volume":"46","author":"Zhang","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2021.173914_bib77","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.parkreldis.2014.08.016","article-title":"Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease","volume":"20","author":"Zhao","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejphar.2021.173914_bib78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2018.07.023","article-title":"Inhibition of microRNA-505 suppressed MPP+-induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson's disease model","volume":"835","author":"Zhu","year":"2018","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:45:57Z","timestamp":1757976357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":78,"alternative-id":["S0014299921000674"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173914","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173914"}}